Straight answers on every compound we stock.
No hype and no dosing protocols — just what each peptide is, what the published literature actually investigates, how to store and handle it in the lab, and how to verify the batch you received. Everything here is for in-vitro research only.
Retatrutide: compound identification and published-literature references for in-vitro laboratory research only, not human or veterinary use. Current labelled amounts, compositions, prices and availability are shown on the catalogue listings. Lot reports are shown only where published.
BPC-157: compound identification and published-literature references for in-vitro laboratory research only, not human or veterinary use. Current labelled amounts, compositions, prices and availability are shown on the catalogue listings. Lot reports are shown only where published.
TB-500: compound identification and published-literature references for in-vitro laboratory research only, not human or veterinary use. Current labelled amounts, compositions, prices and availability are shown on the catalogue listings. Lot reports are shown only where published.
Tirzepatide research guide for Australia: molecular identity, GIP/GLP-1 receptor pharmacology, assay interpretation and primary references. In-vitro research only.
GHK-Cu: compound identification and published-literature references for in-vitro laboratory research only, not human or veterinary use. Current labelled amounts, compositions, prices and availability are shown on the catalogue listings. Lot reports are shown only where published.
Semaglutide: compound identification and published-literature references for in-vitro laboratory research only, not human or veterinary use. Current labelled amounts, compositions, prices and availability are shown on the catalogue listings. Lot reports are shown only where published.
Tesamorelin: compound identification and published-literature references for in-vitro laboratory research only, not human or veterinary use. Current labelled amounts, compositions, prices and availability are shown on the catalogue listings. Lot reports are shown only where published.
Ipamorelin: compound identification and published-literature references for in-vitro laboratory research only, not human or veterinary use. Current labelled amounts, compositions, prices and availability are shown on the catalogue listings. Lot reports are shown only where published.
Epitalon (Epithalon) research guide for Australia: AEDG identity, fibroblast telomerase studies, model limitations and primary references. In-vitro research only.
MK-677 (ibutamoren) research guide for Australia: non-peptide identity, pituitary secretion and receptor-binding studies, assay limits and primary references. In-vitro research only.
Peptide law in Australia: compound identification and published-literature references for in-vitro laboratory research only, not human or veterinary use. Current labelled amounts, compositions, prices and availability are shown on the catalogue listings. Lot reports are shown only where published.
Peptides: compound identification and published-literature references for in-vitro laboratory research only, not human or veterinary use. Current labelled amounts, compositions, prices and availability are shown on the catalogue listings. Lot reports are shown only where published.
Side-by-side comparisons
Deciding between two compounds? These break down the mechanism, handling and current Australian pricing of each, side by side.
Compare the compound identities of BPC-157 and TB-500. Neither is offered for human or veterinary use. A difference in class or labelled amount is not evidence of better quality or therapeutic benefit.
CompareCompare the compound identities of Semaglutide and Tirzepatide. Neither is offered for human or veterinary use. A difference in class or labelled amount is not evidence of better quality or therapeutic benefit.
CompareCompare the compound identities of Retatrutide and Tirzepatide. Neither is offered for human or veterinary use. A difference in class or labelled amount is not evidence of better quality or therapeutic benefit.
CompareCompare the compound identities of Ipamorelin and MK-677. Neither is offered for human or veterinary use. A difference in class or labelled amount is not evidence of better quality or therapeutic benefit.
CompareCompare the compound identities of GHK-Cu and BPC-157. Neither is offered for human or veterinary use. A difference in class or labelled amount is not evidence of better quality or therapeutic benefit.
Compare